Robert Ng is a Gene Therapy and Editing Scientific Lead dedicated to advancing gene therapy strategies to address various genetic diseases. Currently, they serve as the Executive Director of Vector Engineering and Delivery at Eli Lilly and Company, following a position as Head of Genetic Technology and Innovation at Akouos. Robert previously contributed as a scientist at Voyager Therapeutics, CRISPR Therapeutics, and BioMarin Pharmaceutical Inc. Their academic credentials include a PhD in Biochemistry and Molecular Biology from the University of Florida, alongside executive degrees in Healthcare Leadership from Cornell University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices